A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
ABLIM2 | Actin binding LIM protein family, member 2 | | | | | | Tissue enhanced |
ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
AC002472.13 | Leucine-rich repeat-containing protein LOC400891 | | | | | | Tissue enhanced |
AC004017.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC005481.5 | Uncharacterized protein | | | | | | Tissue enhanced |
AC005841.1 | Uncharacterized protein ENSP00000372125 | | | | | | Tissue enhanced |
AC006486.9 | Uncharacterized protein | | | | | | Tissue enhanced |
AC007382.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC007421.1 | | | | | | | Tissue enhanced |
AC007461.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC007952.5 | Uncharacterized protein ENSP00000382042 | | | | | | Tissue enhanced |
AC007952.6 | Uncharacterized protein | | | | | | Tissue enhanced |
AC008060.7 | HCG2000720; Hypothetical gene supported by AK054822; Uncharacterized protein | | | | | | Tissue enhanced |
AC008964.1 | | | | | | | Tissue enhanced |
AC009060.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC011897.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC012123.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC012215.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC016885.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC018630.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC018816.3 | Uncharacterized protein | | | | | | Tissue enhanced |
AC020907.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC021218.2 | Uncharacterized protein | | | | | | Tissue enhanced |
AC022431.2 | Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. | | | | | | Tissue enhanced |
AC023590.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC026703.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
AC026740.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC037459.4 | Uncharacterized protein | | | | | | Tissue enhanced |